Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Cavalcanti, Yone Vila Nova ^a,b   Brelaz, Maria Carolina Accioly ^b   Neves, Juliana Kelle De Andrade Lemoine ^b   Ferraz, José Candido ^c   Pereira, Valéria Rêgo Alves ^b  

^a UNIVERSIDADE FEDERAL RURAL DE PERNAMBUCO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BACTERIAL STRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL TYPE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; HOUSEHOLD; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; LUNG TUBERCULOSIS; LYSOSOME; MACROPHAGE; MEDIATOR; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; VIRUS REPLICATION;

EID: 84876511352     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/745483     Document Type: Review

References (108)

1. Sato D. N., e Silva C. H. P. M., Mycobacterium. Bacteriologia-um texto ilustrado 1999 Rio de Janeiro, Brazil Eventos 285 315
2. WHO, Global Tuberculosis Control 2011
3. WHO, The Global Plan Tuberculosis to Stop TB, 2011-2015 2012
4. Baliza M., Bach A. H., de Queiroz G. L., Melo I. C., Carneiro M. M., de Albuquerque M. D. F. P. M., Suffys P., Rodrigues L., Ximenes R., Lucena-Silva N., High frequency of resistance to the drugs isoniazid and rifampicin among tuberculosis cases in the City of Cabo de Santo Agostinho, an urban area in Northeastern Brazil. Revista da Sociedade Brasileira de Medicina Tropical 2008 41 1 11 16 2-s2.0-41549101119 10.1590/S0037-86822008000100003 (Pubitemid 351467571)
5. Tomioka H., Tatano Y., Sano C., Shimizu T., Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks. Journal of Infection and Chemotherapy 2011 17 3 302 317 2-s2.0-78651354597 10.1007/s10156-010-0177-y
6. Corbett E. L., Watt C. J., Walker N., Maher D., Williams B. G., Raviglione M. C., Dye C., The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Medicine 2003 163 9 1009 1021 2-s2.0-0012746992 10.1001/archinte.163.9.1009 (Pubitemid 36548927)
7. Frieden T. R., Sterling T. R., Munsiff S. S., Watt C. J., Dye C., Tuberculosis. The Lancet 2003 362 9387 887 899 2-s2.0-0141853344 10.1016/S0140-6736(03)14333-4 (Pubitemid 37130100)
8. Dooley K. E., Chaisson R. E., Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 2009 9 12 737 746 2-s2.0-71549126811 10.1016/S1473-3099(09)70282-8
9. Kinjo Y., Kawakami K., Uezu K., Yara S., Miyagi K., Koguchi Y., Hoshino T., Okamoto M., Kawase Y., Yokota K., Yoshino K., Takeda K., Akira S., Saito A., Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. Journal of Immunology 2002 169 1 323 329 2-s2.0-0036644065 (Pubitemid 34686152)
10. Wang C. H., Lin H. C., Liu C. Y., Huang K. H., Huang T. T., Yu C. T., Kuo H. P., Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. International Journal of Tuberculosis and Lung Disease 2001 5 3 283 291 2-s2.0-0035032518
11. Gupta A., Kaul A., Tsolaki A. G., Kishore U., Bhakta S., Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 2012 217 3 363 374 2-s2.0-79960861392 10.1016/j.imbio.2011.07.008
12. Cooper A. M., Khader S. A., The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunological Reviews 2008 226 1 191 204 2-s2.0-55149116512 10.1111/j.1600-065X.2008.00702.x
13. Lawn S. D., Myer L., Edwards D., Bekker L. G., Wood R., Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009 23 13 1717 1725 2-s2.0-69149102219 10.1097/QAD.0b013e32832d3b6d
14. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunology 2007 8 4 369 377 2-s2.0-34248562792 10.1038/ni1449 (Pubitemid 46745412)
15. Lin P. G., Flynn J. L., Understanding latent tuberculosis: a moving target. Journal of Immunology 2010 185 1 15 22 2-s2.0-77956216718 10.4049/jimmunol.0903856
16. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunology 2005 6 11 1123 1132 2-s2.0-27544490377 10.1038/ni1254 (Pubitemid 41541790)
17. Park H., Li Z., Yang X. O., Chang S. H., Nurieva R., Wang Y. H., Wang Y., Hood L., Zhu Z., Tian Q., Dong C., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 2005 6 11 1133 1141 2-s2.0-27544465354 10.1038/ni1261 (Pubitemid 41541791)
18. + memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunology 2009 2 5 439 449 2-s2.0-69249153068 10.1038/mi.2009.90
19. Torrado E., Cooper A. M., IL-17 and Th17 cells in tuberculosis. Cytokine and Growth Factor Reviews 2010 21 6 455 462 2-s2.0-78649687687 10.1016/j.cytogfr.2010.10.004
20. Wozniak T. M., Saunders B. M., Ryan A. A., Britton W. J., Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of γ interferon. Infection and Immunity 2010 78 10 4187 4194 2-s2.0-77957735367 10.1128/IAI.01392-09
21. Moutinho I. L. D., Tuberculose: aspectos imunológicos na infecção e na doença. Revista Médica de Minas Gerais 2011 21 1 42 48
22. Dinarello C. A., Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology 2009 27 519 550 2-s2.0-62649139025 10.1146/annurev.immunol.021908.132612
23. Garlanda C., Di Liberto D., Vecchi A., la Manna M. P., Buracchi C., Caccamo N., Salerno A., Dieli F., Mantovani A., Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. Journal of Immunology 2007 179 5 3119 3125 2-s2.0-38449105679
24. Katrin D. M.-B., Andrade B. B., Barber D. L., Hieny S., Feng C. G., Caspar P., Oland S., Gordon S., Sher A., Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 2011 35 6 1023 1034 10.1016/j.immuni.2011.12.002
25. Guler R., Parihar S. P., Spohn G., Johansen P., Brombacher F., Bachmann M. F., Blocking IL-1 α but not IL-1 β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice. Vaccine 2011 29 6 1339 1346 2-s2.0-78751578879 10.1016/j.vaccine.2010.10.045
26. Carswell E. A., Old L. J., Kassel, Green R. L., Fiore N., Williamson B., An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences of the United States of America 1975 72 9 3666 3670 10.1073/pnas.72.9.3666
27. Barnes P. F., Lu S., Abrams J. S., Wang E., Yamamura M., Modlin R. L., Cytokine production at the site of disease in human tuberculosis. Infection and Immunity 1993 61 8 3482 3489 2-s2.0-0027181101 (Pubitemid 23223442)
28. Ladel C. H., Szalay G., Riedel D., Kaufmann S. H. E., Interleukin-12 secretion by Mycobacterium tuberculosis -infected macrophages. Infection and Immunity 1997 65 5 1936 1938 2-s2.0-0030981997 (Pubitemid 27193622)
29. Serbina N. V., Flynn J. L., Early emergence of CD8+ T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis -infected mice. Infection and Immunity 1999 67 8 3980 3988 2-s2.0-0032792687 (Pubitemid 29357018)
30. Yu K., Mitchell C., Xing Y., Magliozzo R. S., Bloom B. R., Chan J., Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tubercle and Lung Disease 1999 79 4 191 198 2-s2.0-0032830066 10.1054/tuld.1998.0203 (Pubitemid 29446005)
31. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. Journal of Experimental Medicine 2000 192 3 347 358 2-s2.0-0034617993 10.1084/jem.192.3.347 (Pubitemid 30629160)
32. Mohan V. P., Scanga C. A., Yu K., Scott H. M., Tanaka K. E., Tsang E., Tsai M. C., Flynn J. L., Chan J., Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infection and Immunity 2001 69 3 1847 1855 2-s2.0-0035118698 10.1128/IAI.69.3.1847-1855.2001 (Pubitemid 32187645)
33. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W., Bloom B. R., Tumor necrosis factor- α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995 2 6 561 572 2-s2.0-0028979703
34. Bean A. G. D., Roach D. R., Briscoe H., France M. P., Korner H., Sedgwick J. D., Britton W. J., Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. Journal of Immunology 1999 162 6 3504 3511 2-s2.0-0033559125 (Pubitemid 29313602)
35. Flynn J. L., Scanga C. A., Tanaka K. E., Chan J., Effects of aminoguanidine on latent murine tuberculosis. Journal of Immunology 1998 160 4 1796 1803 2-s2.0-0032519735 (Pubitemid 28106466)
36. Dlugovitzky D., Bay M. L., Rateni L., Fiorenza G., Vietti L., Farroni M. A., Bottasso O. A., Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clinical and Experimental Immunology 2000 122 3 343 349 2-s2.0-0034535335 10.1046/j.1365-2249.2000.01394.x (Pubitemid 32002191)
37. Al-Attiyah R., El-Shazly A., Mustafa A. S., Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients. Scandinavian Journal of Immunology 2012 75 6 623 632 2-s2.0-84861462913 10.1111/j.1365-3083.2012.02692.x
38. Moura E. P., Avaliação da resposta immune cellular e humoral antes e depois do tratamento da tuberculose pulmonar. Tese, p. 90, 2002
39. Juárez E., Carranza C., Hernández-Sánchez F., León-Contreras J. C., Hernández-Pando R., Escobedo D., Torres M., Sada E., NOD2 enhances the innate response of alveolar macrophages to Mycobacterium tuberculosis in humans. European Journal of Immunology 2012 42 4 880 889 2-s2.0-84860241844 10.1002/eji.201142105
40. Maini R. N., Taylor P. C., Paleolog E., Charles P., Ballara S., Brennan F. M., Feldmann M., Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Annals of the Rheumatic Diseases 1999 58 1 I56 I60 2-s2.0-0032705588
41. Solovic I., Sester M., Gomez-Reino J. J., Rieder H. L., Ehlers S., Milburn H. J., Kampmann B., Hellmich B., Groves R., Schreiber S., Wallis R. S., Sotgiu G., Schölvinck E. H., Goletti D., Zellweger J. P., Diel R., Carmona L., Bartalesi F., Ravn P., Bossink A., Duarte R., Erkens C., Clark J., Migliori G. B., Lange C., The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. European Respiratory Journal 2010 36 5 1185 1206 2-s2.0-78349243317 10.1183/09031936.00028510
42. Stallmach A., Hagel S., Bruns T., Adverse effects of biologics used for treating IBD. Best Practice and Research: Clinical Gastroenterology 2010 24 2 167 182 2-s2.0-77749343028 10.1016/j.bpg.2010.01.002
43. Flynn J. L., Chan J., Lin P. L., Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunology 2011 4 3 271 278 2-s2.0-79955111092 10.1038/mi.2011.14
44. Bekker L. G., Moreira A. L., Bergtold A., Freeman S., Ryffel B., Kaplan G., Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infection and Immunity 2000 68 12 6954 6961 2-s2.0-0034440521 10.1128/IAI.68.12.6954-6961.2000 (Pubitemid 32463408)
45. Ehlers S., Benini J., Held H. D., Roeck C., Alber G., Uhlig S., α β T cell receptor-positive cells and interferon- γ but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. Journal of Experimental Medicine 2001 194 12 1847 1859 2-s2.0-0035904851 10.1084/jem.194.12.1847 (Pubitemid 34028663)
46. Jönsson B., Ridell M., Wold A. E., Phagocytosis and cytokine response to rough and smooth colony variants of mycobacterium abscessus byhuman peripheral blood mononuclear cells. Acta Pathologica, Microbiologica et Immunologica Scandinavica. In press 10.1111/j.1600-0463.2012.02932.x
47. Dambuza I., Allie N., Fick L., Johnston N., Fremond C., Mitchell J., Quesniaux V. F. J., Ryffel B., Jacobs M., Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence. Tuberculosis 2008 88 3 221 234 2-s2.0-43049153009 10.1016/j.tube.2007.08.011 (Pubitemid 351635899)
48. Keane J., Remold H. G., Kornfeld H., Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. Journal of Immunology 2000 164 4 2016 2020 2-s2.0-0034651738 (Pubitemid 30108758)
49. Robinson C. M., Jung J. Y., Nau G. J., Interferon- γ tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages. Cytokine 2012 60 1 233 241 10.1016/j.cyto.2012.06.012
50. Manca C., Reed M. B., Freeman S., Mathema B., Kreiswirth B., Barry C. E., Kaplan G., Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infection and Immunity 2004 72 9 5511 5514 2-s2.0-4544380418 10.1128/IAI.72.9.5511-5514.2004 (Pubitemid 39223445)
51. van Kooyk Y., Geijtenbeek T. B. H., DC-SIGN: escape mechanism for pathogens. Nature Reviews Immunology 2003 3 9 697 709 2-s2.0-0141688292 10.1038/nri1182 (Pubitemid 41070811)
52. Seah G. T., Rook G. A. W., IL-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF- α Journal of Immunology 2001 167 3 1230 1237 2-s2.0-0035421789 (Pubitemid 32703117)
53. Stenger S., Immunological control of tuberculosis: role of tumour necrosis factor and more. Annals of the Rheumatic Diseases 2005 64 supplement 4 iv24 iv28 2-s2.0-27444432605 10.1136/ard.2005.042531 (Pubitemid 41532012)
54. Bocchino M., Galati D., Sanduzzi A., Colizzi V., Brunetti E., Mancino G., Role of mycobacteria-induced monocyte/macrophage apoptosis in the pathogenesis of human tuberculosis. International Journal of Tuberculosis and Lung Disease 2005 9 4 375 383 2-s2.0-17144415540 (Pubitemid 40524027)
55. Isaacs A., Lindenmann J., Valentine R. C., Virus interference. II. Some properties of interferon. Proceedings of the Royal Society of London, Series B 1957 1471 927 268 273
56. Schreiber G. H., Schereiber R. D., Thomson A. W., Lotze M. T., Interferon- γ The Cytokine Handbook 1 4th chapter 24 New York, NY, USA Elsevier 567 601
57. Flesch I. E. A., Hess J. H., Huang S., Aguet M., Rothe J., Bluethmann H., Kaufmann S. H. E., Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α Journal of Experimental Medicine 1995 181 5 1615 1621 2-s2.0-0028943066
58. Fenton M. J., Vermeulen M. W., Kim S., Burdick M., Strieter R. M., Kornfeld H., Induction of γ interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infection and Immunity 1997 65 12 5149 5156 2-s2.0-0030729227 (Pubitemid 27513563)
59. Oberholzer A., Oberholzer C., Moldawer L. L., Cytokine signaling-regulation of the immune response in normal and critically ill states. Critical Care Medicine 2000 28 4, supplement N3 N12 2-s2.0-0034015682 (Pubitemid 30262043)
60. Cooper A. M., Cell-mediated immune responses in tuberculosis. Annual Review of Immunology 2009 27 393 422 2-s2.0-67650932256 10.1146/annurev.immunol. 021908.132703
61. Gehring A. J., Rojas R. E., Canaday D. H., Lakey D. L., Harding C. V., Boom W. H., The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits γ interferon-regulated HLA-DR and Fc γ R1 on human macrophages through toll-like receptor 2. Infection and Immunity 2003 71 8 4487 4497 2-s2.0-0042766347 10.1128/IAI.71.8.4487-4497.2003 (Pubitemid 36919915)
62. Harding C. V., Pai R. K., Convery M., Hamilton T. A., Henry Boom W., Inhibition of IFN- γ -induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. Journal of Immunology 2003 171 1 175 184 2-s2.0-0037530648 (Pubitemid 36745286)
63. Tavares R. C. O., Salgado J., Moreira V. B., Ferreira M. A. S., Mello F. C. Q., Leung J. A. W., Singh M., Fonseca L. D. S., Saad M. H. F., Cell proliferation and interferon- γ response to recombinant MBP-3, NarL, MT-10.3, and 16kDa Mycobacterium tuberculosis antigens in Brazilian tuberculosis patients. Memorias do Instituto Oswaldo Cruz 2006 101 8 857 861 2-s2.0-33846353542 (Pubitemid 46129485)
64. Nienhaus A., Schablon A., Diel R., Interferon- γ release assay for the diagnosis of latent TB infection-analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE 2008 3 7 2-s2.0-50549087699 10.1371/journal.pone.0002665 e2665
65. Costa J. C. T., Silva R., Sá R., Cardoso M. J., Ribeiro C., Nienhaus A., Comparison of interferon- γ release assay and tuberculin test for screening in healthcare workers. Revista Portuguesa de Pneumologia 2010 16 2 211 221 2-s2.0-77955716977
66. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G., Orme I. M., Disseminated tuberculosis in interferon γ gene-disrupted mice. Journal of Experimental Medicine 1993 178 6 2243 2247 2-s2.0-0027482327 10.1084/jem.178.6.2243 (Pubitemid 23344885)
67. Flynn J. L., Chan J., Triebold K. J., Dalton D. K., Stewart T. A., Bloom B. R., An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. Journal of Experimental Medicine 1993 178 6 2249 2254 2-s2.0-0027360333 10.1084/jem.178.6.2249 (Pubitemid 23344886)
68. Newport M. J., Huxley C. M., Huston S., Hawrylowicz C. M., Oostra B. A., Williamson R., Levin M., A mutation in the interferon- γ -receptor gene and susceptibility to mycobacterial infection. The New England Journal of Medicine 1996 335 26 1941 1949 2-s2.0-0030467174 10.1056/NEJM199612263352602 (Pubitemid 26428218)
69. Ottenhoff T. H. M., Verreck F. A. W., Hoeve M. A., van de Vosse E., Control of human host immunity to mycobacteria. Tuberculosis 2005 85 1-2 53 64 2-s2.0-15944421766 10.1016/j.tube.2004.09.011 (Pubitemid 40431316)
70. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J. F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., Casanova J. L., Interferon- γ -receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. The New England Journal of Medicine 1996 335 26 1956 1961 2-s2.0-0030455878
71. Casanova J. L., Abel L., Genetic dissection of immunity to mycobacteria: the human model. Annual Review of Immunology 2002 20 581 620 2-s2.0-0036219062 10.1146/annurev.immunol.20.081501.125851 (Pubitemid 34293435)
72. Cooke G. S., Hill A. V. S., Genetics of susceptibility to human infectious disease. Nature Reviews Genetics 2001 2 12 967 977 2-s2.0-0035653671 10.1038/35103577 (Pubitemid 33691093)
73. Algood H. M. S., Chan J., Flynn J. L., Chemokines and tuberculosis. Cytokine and Growth Factor Reviews 2003 14 6 467 477 2-s2.0-0142054833 10.1016/S1359-6101(03)00054-6 (Pubitemid 37296020)
74. García V. E., Uyemura K., Sieling P. A., Ochoa M. T., Morita C. T., Okamura H., Kurimoto M., Rea T. H., Modlin R. L., IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. Journal of Immunology 1999 162 10 6114 6121 2-s2.0-0033563009 (Pubitemid 29314972)
75. Vankayalapati R., Wizel B., Weis S. E., Samten B., Girard W. M., Barnes P. F., Production of interleukin-18 in human tuberculosis. Journal of Infectious Diseases 2000 182 1 234 239 2-s2.0-0033930337 10.1086/315656 (Pubitemid 30497809)
76. Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S., Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18- gene-disrupted mice. Infection and Immunity 1999 67 5 2585 2589 2-s2.0-0032924518 (Pubitemid 29200522)
77. Morosini M., Meloni F., Bianco A. M., Paschetto E., Uccelli M., Pozzi E., Fietta A., The assessment of IFN- γ and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease 2003 7 10 994 1000 2-s2.0-0141963840 (Pubitemid 37237064)
78. Dlugovitzky D., Torres-Morales A., Rateni L., Farroni M. A., Largacha C., Molteni O., Bottasso O., Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunology and Medical Microbiology 1997 18 3 203 207 2-s2.0-0030773813 10.1016/S0928-8244(97)00040-0 (Pubitemid 27323702)
79. Dlugovitzky D., Bay M. L., Rateni L., Urízar L., Rondelli C. F. M., Largacha C., Farroni M. A., Molteni O., Bottasso O. A., In vitro synthesis of interferon- γ interleukin-4, transforming growth factor- β and interleukin-1 β by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement. Scandinavian Journal of Immunology 1999 49 2 210 217 2-s2.0-0033045726 10.1046/j.1365-3083. 1999.00492.x (Pubitemid 29096319)
80. Torres M., Herrera T., Villareal H., Rich E. A., Sada E., Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infection and Immunity 1998 66 1 176 180 2-s2.0-0031965590
81. Wolf A. J., Linas B., Trevejo-Nuñez G. J., Kincaid E., Tamura T., Takatsu K., Ernst J. D., Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. Journal of Immunology 2007 179 4 2509 2519 2-s2.0-34848910546
82. Khader S. A., Partida-Sanchez S., Bell G., Jelley-Gibbs D. M., Swain S., Pearl J. E., Ghilardi N., DeSauvage F. J., Lund F. E., Cooper A. M., Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. Journal of Experimental Medicine 2006 203 7 1805 1815 2-s2.0-33745812070 10.1084/jem.20052545 (Pubitemid 44036285)
83. Demangel C., Bertolino P., Britton W. J., Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. European Journal of Immunology 2002 32 4 994 1002 2-s2.0-0036235268 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.0.CO;2-6 (Pubitemid 34428814)
84. Jung Y. J., Ryan L., LaCourse R., North R. J., Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. Journal of Experimental Medicine 2005 201 12 1915 1924 2-s2.0-22344448429 10.1084/jem.20050265 (Pubitemid 41002928)
85. Fan L., Xiao H., Hu Z., Ernst J. D., Variation of Mycobacterium tuberculosis antigen-specific IFN-c and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects. PLoS ONE 2012 8 e42716 10.1371/journal.pone.0042716
86. Fiorentino D. F., Bond M. W., Mosmann T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. Journal of Experimental Medicine 1989 170 6 2081 2095 2-s2.0-0024408824 10.1084/jem.170.6.2081 (Pubitemid 20010086)
87. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. Journal of Immunology 1993 150 11 4754 4765 2-s2.0-0027232788 (Pubitemid 23150343)
88. Schandene L., Alonso-Vega C., Willems F., Gérard C., Delvaux A., Velu T., Devos R., de Boer M., Goldman M., B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. Journal of Immunology 1994 152 9 4368 4374 2-s2.0-0028181890
89. Fulton S. A., Cross J. V., Toossi Z. T., Boom W. H., Regulation of interleukin-12 by interleukin-10, transforming growth factor- β tumor necrosis factor- α and interferon- γ in human monocytes infected with Mycobacterium tuberculosis H37Ra. Journal of Infectious Diseases 1998 178 4 1105 1114 2-s2.0-0031657432 (Pubitemid 28452205)
90. Flynn J. L., Chan J., Immunology of tuberculsis. Annual Review of Immunology 2001 19 93 129 10.1146/annurev.immunol.19.1.93 (Pubitemid 32368031)
91. D'Andrea A., Aste-Amezaga M., Valiante N. M., Ma X., Kubin M., Trinchieri G., Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ -production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. Journal of Experimental Medicine 1993 178 3 1041 1048 2-s2.0-0027240219 (Pubitemid 23260442)
92. Murray P. J., Young R. A., Increased antimycobacterial immunity in interleukin-10-deficient mice. Infection and Immunity 1999 67 6 3087 3095 2-s2.0-0033048886 (Pubitemid 29244734)
93. Beamer G. L., Flaherty D. K., Assogba B. D., Stromberg P., Gonzalez-Juarrero M., de Waal Malefyt R., Vesosky B., Turner J., Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. Journal of Immunology 2008 181 8 5545 5550 2-s2.0-54049132852
94. Henao M. I., Montes C., París S. C., García L. F., Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis 2006 86 1 11 19 2-s2.0-29144481006 10.1016/j.tube.2005.03.001 (Pubitemid 41797654)
95. Boussiotis V. A., Tsai E. Y., Yunis E. J., Thim S., Delgado J. C., Dascher C. C., Berezovskaya A., Roussec D., Reynes J. M., Goldfeld A. E., IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. Journal of Clinical Investigation 2000 105 9 1317 1325 2-s2.0-12944310982 (Pubitemid 30266085)
96. + α β T-cell-receptor-positive (TCR+) and γ δ TCR+ T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β Infection and Immunity 1999 67 12 6461 6472 2-s2.0-0032702441
97. Almeida A. S., Lago P. M., Boechat N., Huard R. C., Lazzarini L. C. O., Santos A. R., Nociari M., Zhu H., Perez-Sweeney B. M., Bang H., Ni Q., Huang J., Gibson A. L., Flores V. C., Pecanha L. R., Kritski A. L., Lapa E Silva J. R., Ho J. L., Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. Journal of Immunology 2009 183 1 718 731 2-s2.0-68949135595 10.4049/jimmunol.0801212
98. Weir R. E., Black G. F., Dockrell H. M., Floyd S., Fine P. E. M., Chaguluka S. D., Stenson S., King E., Nazareth B., Warndorff D. K., Ngwira B., Crampin A. C., Mwaungulu L., Sichali L., Jarman E., Donovan L., Blackwell J. M., Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor α interleukin-1 β (IL-1 β), and IL-10 responses compared to those of adolescents in the United Kingdom. Infection and Immunity 2004 72 3 1807 1811 2-s2.0-10744229595 10.1128/IAI.72.3.1807-1811.2004 (Pubitemid 38263808)
99. Shin H. D., Park B. L., Kim L. H., Cheong H. S., Lee I. H., Park S. K., Common interleukin 10 polymorphism associated with decreased risk of tuberculosis. Experimental and Molecular Medicine 2005 37 2 128 132 2-s2.0-18744363936 (Pubitemid 40676922)
100. Pereira C. B., Palaci M., Leite O. H. M., Duarte A. J. S., Benard G., Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes and Infection 2004 6 1 25 33 2-s2.0-1642493660 10.1016/j.micinf.2003. 10.007 (Pubitemid 38114818)
101. Awomoyi A. A., Marchant A., Howson J. M. M., McAdam K. P. W. J., Blackwell J. M., Newport M. J., Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. Journal of Infectious Diseases 2002 186 12 1808 1814 2-s2.0-0037114921 10.1086/345920 (Pubitemid 35463514)
102. + T cell counts have impaired Th1 responses. Journal of Immunology 1997 158 1 492 500 2-s2.0-0030636796 (Pubitemid 127483893)
103. Gazeta C. E., Santos G M. L. S., Vendramini S. H. F., Pinto Neto J. M., Villa T. C. S., Controle de comunicantes de tuberculose no Brasil: Revisão de literatura (1984-2004). Revista Latino-Americana de Enfermagem 2008 16 2 306 313
104. Demissie A., Abebe M., Aseffa A., Rook G., Fletcher H., Zumla A., Weldingh K., Brock I., Andersen P., Doherty T. M., Chintu C., Mulundu G., Mwaba P., McAdam K. P. W. J., Owiafe P., Warndorff D., Lienhardt C., Brookes R., Hill P., Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4 δ 2. Journal of Immunology 2004 172 11 6938 6943 2-s2.0-2442692860 (Pubitemid 38669133)
105. Demissie A., Wassie L., Abebe M., Aseffa A., Rook G., Zumla A., Andersen P., Doherty T. M., Fletcher H., Chintu C., Mulundu G., Mwaba P., McAdam K. P. W. J., Owiafe P., Warndorff D., Lienhardt C., Brookes R., Hill P., The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of γ interferon. Infection and Immunity 2006 74 5 2817 2822 2-s2.0-33646379337 10.1128/IAI.74.5.2817-2822.2006 (Pubitemid 43672991)
106. Cavalcanti Y. V. N., Pereira V. R. A., Reis L. C., Ramos A. L. G., Luna C. F., Nascimento E. J. M., Lucena-Silva N., Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases. Journal of Clinical Laboratory Analysis 2009 23 1 57 62 2-s2.0-58849157443 10.1002/jcla.20290
107. Olobo J. O., Geletu M., Demissie A., Eguale T., Hiwot K., Aderaye G., Britton S., Circulating TNF- α TGF- β and IL-10 in tuberculosis patients and healthy contacts. Scandinavian Journal of Immunology 2001 53 1 85 91 2-s2.0-0035154749 10.1046/j.1365-3083.2001.00844.x (Pubitemid 32113361)
108. Sharpe S. A., Eschelbach E., Basaraba R. J., Gleeson F., Hall G. A., McIntyre A., Williams A., Kraft S. L., Clark S., Gooch K., Hatch G., Orme I. M., Marsh P. D., Dennis M. J., Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis. Tuberculosis 2009 89 6 405 416 2-s2.0-71549144961 10.1016/j.tube.2009.09.002